ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Fisman DN, 2000. Hemophagocytic syndromes and infection. Emerg Infect Dis 6: 601–608.
-
2.
Neofytou E, Sourvinos G, Asmarianaki M, Spandidos DA, Makrigiannakis A, 2008. Prevalence of human herpes virus types 1–7 in the semen of men attending an infertility clinic and correlation with semen parameters. Fertil Steril 85: 420–421.
-
3.
Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC, 2008. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 13: pii8026.
-
4.
World Health Organization, 2008. Epidemic and Pandemic Alert Response: Influenza A (H1N1) Virus Resistance to Oseltamivir. Avaliable at: http://www.who.int/csr/disease/influenza/h1n1_table/en/index.html. Accessed February 10, 2009.
-
5.
Centers for Disease Control and Prevention, 2008. CDC Issues Interim Recommendations for the Use of Influenza Antiviral Medications in the Setting of Oseltamivir Resistance Among Circulating Influenza A (H1N1) Viruses, 2008–09 Influenza Season. Available at: http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279. Accessed February 10, 2009.
-
6.
Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA, 2002. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55: 307–317.
-
7.
Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto AS, 2004. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190: 1627–1630.
-
8.
Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA, 2007. Neuraminidase inhibitorresistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol 81: 12418–12426.
-
9.
Risdall RJ, McKenna RW, Nesbit ME, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD, 1979. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993–1002.
-
10.
Kereveur A, McIlroy D, Samri A, Oksenhendler E, Clauvel JP, Autran B, 1999. Up-regulation of adhesion and MHC molecules onsplenic monocyte/macrophages in adult haemophagocytic syndrome. Br J Haematol 104: 871–877.
-
11.
Dellinger RP, 2003. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 36: 1259–1265.
-
12.
Watanabe M, Shibuya A, Okuno J, Maeda T, Tamama S, Saigenji K, 2002. Hepatitis A virus infection associated with hemophagocytic syndrome: report of two cases. Intern Med 41: 1188–1192.
-
13.
Koizumi K, Yokoyama K, Nishio M, Shibata S, Ozutumi K, Yamaguchi M, Sato N, Yasukouchi T, Sawada K, Koike T, 1996. A case with virus-associated hemophagocytic syndrome (VAHS) complicated by rhabdomyolysis which were associated with herpes-simplex virus infection. Jpn J Clin Hematol 37: 40–45.
-
14.
Fujiki R, Shiraishi K, Noda K, Ohshita Y, Fukahori S, Johjima H, Tanaka K, Rikimaru T, Aizawa H, 2003. A case of hemophagocytic syndrome associated with military tuberculosis. Kekkaku 78: 443–448.
-
15.
Goto S, Aoike I, Shibasaki Y, Morita T, Miyazaki S, Shimizu T, Suzuki M, 2001. A successfully treated case of disseminated tuberculosis-associated hemophagocytic syndrome and multiple organ dysfunction syndrome. Am J Kidney Dis 38: E19.
-
16.
Sanada S, Ookawara S, Shindo T, Morino K, Ishikawa H, Suzuki M, 2004. A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome. Therap Aphre Dialy 8: 503–506.
-
17.
Aouba A, Noguera ME, Clauvel JP, Quint L, 2000. Hemophagocytic syndrome associated with Plasmodium vivax infection. Br J Haematol 103: 832–833.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 207 | 174 | 6 |
| Full Text Views | 267 | 10 | 0 |
| PDF Downloads | 72 | 8 | 0 |
Novel Swine-Origin Influenza A (H1N1) Virus-Associated Hemophagocytic Syndrome—A First Case Report
Yishan Zheng
Yishan Zheng
Intensive Care Unit of Second Affiliated Hospital of Southeast University, Nanjing, China; Department of Respiratory Disease of Jiangsu Provincial People's Hospital, Nanjing, China
Search for other papers by Yishan Zheng in
Current site
Google Scholar
PubMed
Search for other papers by Yishan Zheng in
Current site
Google Scholar
PubMed
Yongfeng Yang
Yongfeng Yang
Intensive Care Unit of Second Affiliated Hospital of Southeast University, Nanjing, China; Department of Respiratory Disease of Jiangsu Provincial People's Hospital, Nanjing, China
Search for other papers by Yongfeng Yang in
Current site
Google Scholar
PubMed
Search for other papers by Yongfeng Yang in
Current site
Google Scholar
PubMed
Wei Zhao
Wei Zhao
Intensive Care Unit of Second Affiliated Hospital of Southeast University, Nanjing, China; Department of Respiratory Disease of Jiangsu Provincial People's Hospital, Nanjing, China
Search for other papers by Wei Zhao in
Current site
Google Scholar
PubMed
Search for other papers by Wei Zhao in
Current site
Google Scholar
PubMed
Hong Wang
Hong Wang
Intensive Care Unit of Second Affiliated Hospital of Southeast University, Nanjing, China; Department of Respiratory Disease of Jiangsu Provincial People's Hospital, Nanjing, China
Search for other papers by Hong Wang in
Current site
Google Scholar
PubMed
Search for other papers by Hong Wang in
Current site
Google Scholar
PubMed
Secondary or reactive hemophagocytic syndrome (HPS) is frequently related to viral infections. However, the novel swine-origin influenza A (H1N1) virus associated HPS has never been reported. On October 10, 2009, a 17-year-old female child with no past medical history, complaining of severe asthenia, pneumonia, myalgia, and high fever, was admitted to our department, and H1N1 DNA was detected. Five days after her hospitalization, all signs and symptoms aggravated into HPS. After treatment for H1N1 influenza, the patient had a recovery and clearance of H1N1 infection 10 days after hospitalization. Three weeks later, the patient was discharged without any complaints, indicating the etiological role of H1N1infection in HPS.
Author Notes
Author's address: Wei Zhao, ICU of Second Affiliated Hospital of Southeast University, Nanjing, 210003 China, E-mail: Doctor0219@163.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Fisman DN, 2000. Hemophagocytic syndromes and infection. Emerg Infect Dis 6: 601–608.
-
2.
Neofytou E, Sourvinos G, Asmarianaki M, Spandidos DA, Makrigiannakis A, 2008. Prevalence of human herpes virus types 1–7 in the semen of men attending an infertility clinic and correlation with semen parameters. Fertil Steril 85: 420–421.
-
3.
Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC, 2008. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 13: pii8026.
-
4.
World Health Organization, 2008. Epidemic and Pandemic Alert Response: Influenza A (H1N1) Virus Resistance to Oseltamivir. Avaliable at: http://www.who.int/csr/disease/influenza/h1n1_table/en/index.html. Accessed February 10, 2009.
-
5.
Centers for Disease Control and Prevention, 2008. CDC Issues Interim Recommendations for the Use of Influenza Antiviral Medications in the Setting of Oseltamivir Resistance Among Circulating Influenza A (H1N1) Viruses, 2008–09 Influenza Season. Available at: http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279. Accessed February 10, 2009.
-
6.
Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA, 2002. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55: 307–317.
-
7.
Herlocher ML, Truscon R, Elias S, Yen HL, Roberts NA, Ohmit SE, Monto AS, 2004. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 190: 1627–1630.
-
8.
Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA, 2007. Neuraminidase inhibitorresistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol 81: 12418–12426.
-
9.
Risdall RJ, McKenna RW, Nesbit ME, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD, 1979. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44: 993–1002.
-
10.
Kereveur A, McIlroy D, Samri A, Oksenhendler E, Clauvel JP, Autran B, 1999. Up-regulation of adhesion and MHC molecules onsplenic monocyte/macrophages in adult haemophagocytic syndrome. Br J Haematol 104: 871–877.
-
11.
Dellinger RP, 2003. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 36: 1259–1265.
-
12.
Watanabe M, Shibuya A, Okuno J, Maeda T, Tamama S, Saigenji K, 2002. Hepatitis A virus infection associated with hemophagocytic syndrome: report of two cases. Intern Med 41: 1188–1192.
-
13.
Koizumi K, Yokoyama K, Nishio M, Shibata S, Ozutumi K, Yamaguchi M, Sato N, Yasukouchi T, Sawada K, Koike T, 1996. A case with virus-associated hemophagocytic syndrome (VAHS) complicated by rhabdomyolysis which were associated with herpes-simplex virus infection. Jpn J Clin Hematol 37: 40–45.
-
14.
Fujiki R, Shiraishi K, Noda K, Ohshita Y, Fukahori S, Johjima H, Tanaka K, Rikimaru T, Aizawa H, 2003. A case of hemophagocytic syndrome associated with military tuberculosis. Kekkaku 78: 443–448.
-
15.
Goto S, Aoike I, Shibasaki Y, Morita T, Miyazaki S, Shimizu T, Suzuki M, 2001. A successfully treated case of disseminated tuberculosis-associated hemophagocytic syndrome and multiple organ dysfunction syndrome. Am J Kidney Dis 38: E19.
-
16.
Sanada S, Ookawara S, Shindo T, Morino K, Ishikawa H, Suzuki M, 2004. A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome. Therap Aphre Dialy 8: 503–506.
-
17.
Aouba A, Noguera ME, Clauvel JP, Quint L, 2000. Hemophagocytic syndrome associated with Plasmodium vivax infection. Br J Haematol 103: 832–833.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 207 | 174 | 6 |
| Full Text Views | 267 | 10 | 0 |
| PDF Downloads | 72 | 8 | 0 |